Andrew Cooper joined Raymond James in June 2013 and the equity research team in June 2014 in the healthcare space. In February 2020 he assumed lead coverage of the diagnostics & clinical laboratories sector with further expansion into the life science tools industry thereafter, though he has experience across many non-therapeutic categories. Cooper graduated from the University of North Carolina at Chapel Hill with a bachelor of science in business administration and political science in May of 2013.